PSTH

More PSTH headlines

18 articles

Billionaire investor Bill Ackman considering deal with Elon Musk's X: report

nypost.com·Oct 1

Bill Ackman reportedly said he would 'absolutely' do a deal with X with his new SPARC funding vehicle

cnbc.com·Oct 1

Bill Ackman's SPAC gets green light from the SEC and he's looking for something to buy

cnbc.com·Sep 29

Bill Ackman will repay investors $4 billion after his SPAC fails

cnn.com·Jul 12

Bill Ackman to close largest SPAC ever, return billions to investors

foxbusiness.com·Jul 12

Bill Ackman says he'll return $4 billion to PSTH investors after failing to close a SPAC deal — and trumpets his next-generation SPARC

markets.businessinsider.com·Jul 12

Bill Ackman's SPAC has just 6 weeks to find a target — or he'll have to return $4 billion to investors

markets.businessinsider.com·Jun 9

Universal Music valued at $39 billion ahead of stock market debut

techxplore.com·Sep 20

France's Vivendi sells 2.9% of Universal to Pershing Square for $1.15 billion

reuters.com·Aug 31

The lawyers that sued Bill Ackman's SPAC are reportedly targeting 50 more as the merger boom deflates

markets.businessinsider.com·Aug 26

Ackman committed to finding a deal for PSTH; sold Agilent to raise cash

reuters.com·Aug 24

What Is A SPARC? Bill Ackman Seeking To Change PSTH Structure Again

benzinga.com·Aug 20

Ackman Prepared to Return SPAC Cash if Regulators Clear New Investment Vehicle

barrons.com·Aug 20

Ackman seeks SPAC relaunch to fix lawsuit's 'harm'

reuters.com·Aug 19

Bill Ackman Facing New Lawsuit After Failed SPAC Deal

benzinga.com·Aug 17

Billionaire investor Bill Ackman's SPAC is reportedly being sued for not operating as a blank-check firm

markets.businessinsider.com·Aug 17

Bill Ackman SPAC sued, plaintiffs say sponsors got 'staggering compensation'

cnbc.com·Aug 17

Vivendi sells a 7.1% stake of UMG to Pershing Square for $2.8 billion

reuters.com·Aug 10
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.